Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdallah Flaifel

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Neurology|December 28, 2020
SARS-CoV-2 Is Not Detected in the Cerebrospinal Fluid of Encephalopathic COVID-19 PatientsDimitris G Placantonakis, Maria Aguero-Rosenfeld, Abdallah Flaifel, et al.
The American Journal of Surgical Pathology|November 12, 2025
Pediatric-Type Follicular Lymphoma of the Conjunctiva: Shared Histologic and Molecular Features With the Nodal CounterpartAbdallah Flaifel, Joao Victor Alves de Castro, Shunyou Gong, et al.
American Journal of Clinical Pathology|January 9, 2022
Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung TransplantationAbdallah Flaifel, Benjamin Kwok, Jane Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR TrialThomas Denize, Subrina Farah, Alessia Cimadamore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUNAbdallah Flaifel, Wanling Xie, David A Braun, et al.
Journal for Immunotherapy of Cancer|November 12, 2020
Prognostic significance and immune correlates of CD73 expression in renal cell carcinomaAbhishek Tripathi, Edwin Lin, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
Genes & Development|November 16, 2019
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesisMatthew G Oser, Amin H Sabet, Wenhua Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|December 28, 2020
SARS-CoV-2 Is Not Detected in the Cerebrospinal Fluid of Encephalopathic COVID-19 PatientsDimitris G Placantonakis, Maria Aguero-Rosenfeld, Abdallah Flaifel, et al.
The American Journal of Surgical Pathology|November 12, 2025
Pediatric-Type Follicular Lymphoma of the Conjunctiva: Shared Histologic and Molecular Features With the Nodal CounterpartAbdallah Flaifel, Joao Victor Alves de Castro, Shunyou Gong, et al.
American Journal of Clinical Pathology|January 9, 2022
Pulmonary Pathology of End-Stage COVID-19 Disease in Explanted Lungs and Outcomes After Lung TransplantationAbdallah Flaifel, Benjamin Kwok, Jane Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2021
Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR TrialThomas Denize, Subrina Farah, Alessia Cimadamore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUNAbdallah Flaifel, Wanling Xie, David A Braun, et al.
Journal for Immunotherapy of Cancer|November 12, 2020
Prognostic significance and immune correlates of CD73 expression in renal cell carcinomaAbhishek Tripathi, Edwin Lin, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2019
Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid FeaturesBradley A McGregor, Rana R McKay, David A Braun, et al.
Genes & Development|November 16, 2019
The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesisMatthew G Oser, Amin H Sabet, Wenhua Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell CarcinomaMiriam Ficial, Opeyemi A Jegede, Miriam Sant'Angelo, et al.
Pageof 3